Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02237781Phase 3Unknown
Phase 3, randomised, open-label trial in female infertility (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Level of Anti-Mullerian Hormone at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02237781.